WO2002000001A3 - HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF - Google Patents

HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF Download PDF

Info

Publication number
WO2002000001A3
WO2002000001A3 PCT/EP2001/007533 EP0107533W WO0200001A3 WO 2002000001 A3 WO2002000001 A3 WO 2002000001A3 EP 0107533 W EP0107533 W EP 0107533W WO 0200001 A3 WO0200001 A3 WO 0200001A3
Authority
WO
WIPO (PCT)
Prior art keywords
igpcr20
protein
receptor
coupled receptor
express
Prior art date
Application number
PCT/EP2001/007533
Other languages
French (fr)
Other versions
WO2002000001A2 (en
Inventor
Frank Wattler
Sigrid Wattler
Paul Trommler
Michael C Nehls
Original Assignee
Ingenium Pharmaceuticals Ag
Frank Wattler
Sigrid Wattler
Paul Trommler
Michael C Nehls
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ingenium Pharmaceuticals Ag, Frank Wattler, Sigrid Wattler, Paul Trommler, Michael C Nehls filed Critical Ingenium Pharmaceuticals Ag
Priority to AU2001287574A priority Critical patent/AU2001287574A1/en
Publication of WO2002000001A2 publication Critical patent/WO2002000001A2/en
Publication of WO2002000001A3 publication Critical patent/WO2002000001A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A novel human G protein-coupled receptor (GPcR) protein, IGPcR20, is identified and characterized. IGPcR20-encoding nucleotides, IGPcR20 proteins and fusion proteins, antibodies to the receptor, host cell expression systems, animal models in which the IGPcR20 gene is mutated, recombinant knock-out animals that do not express IGPcR20 and transgenic animals that express an IGPcR20 transgene are encompasssed by the invention, as are compounds that modulate gene expression or receptor activity of IGPcR20 and their use for drug screening, and diagnosis or treatment of diseases and disorders, particularly cancer, reproductive disorders and infertility related to epididymal dysfunction.
PCT/EP2001/007533 2000-06-30 2001-07-02 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF WO2002000001A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001287574A AU2001287574A1 (en) 2000-06-30 2001-07-02 Human g protein-coupled receptor igpcr20, and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21577700P 2000-06-30 2000-06-30
US60/215,777 2000-06-30

Publications (2)

Publication Number Publication Date
WO2002000001A2 WO2002000001A2 (en) 2002-01-03
WO2002000001A3 true WO2002000001A3 (en) 2002-08-22

Family

ID=22804341

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007533 WO2002000001A2 (en) 2000-06-30 2001-07-02 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF

Country Status (2)

Country Link
AU (1) AU2001287574A1 (en)
WO (1) WO2002000001A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690853B2 (en) 2015-06-29 2023-07-04 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κβ for treatment of disease

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2487419A1 (en) 2002-05-28 2003-12-04 Regents Of The University Of Minnesota Crisp polypeptides as contraceptives and inhibitors of sperm capacitation
WO2005059545A2 (en) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics ans therapeutics for diseases associated with g protein-coupled receptor gpr82 (gpr82)
WO2008071430A1 (en) 2006-12-13 2008-06-19 Qiagen Gmbh Transfection microarrays
WO2008124825A2 (en) 2007-04-10 2008-10-16 Zimmer, Inc. An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
HUE046243T2 (en) 2008-05-28 2020-02-28 Reveragen Biopharma Inc Non-hormonal steroid modulators of NF-KB for treatment of disease
US8317622B2 (en) 2008-09-08 2012-11-27 Wms Gaming, Inc. Wagering game establishment data import/export architecture
WO2010133294A2 (en) 2009-05-18 2010-11-25 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and atomizer
AT508698B1 (en) * 2009-08-20 2017-07-15 Blum Gmbh Julius FURNITURE WITH PLATE ARRANGEMENT
US8819172B2 (en) 2010-11-04 2014-08-26 Digimarc Corporation Smartphone-based methods and systems
EP2561125A1 (en) * 2010-04-21 2013-02-27 Battelle Memorial Institute Fibers containing ferrates and methods
US9200172B2 (en) * 2010-11-05 2015-12-01 City University Of Hong Kong Phthalocyanine/ polymer nanocomposite ink for optoelectonics
CN102469573B (en) * 2010-11-16 2015-10-21 中兴通讯股份有限公司 A kind of collocation method of symbol number of physical downlink control channels and device
CN202069706U (en) * 2011-02-28 2011-12-14 北京圣玛特科技有限公司 Metal self-locking bracket slot with working wing with locking device
EP2691545B1 (en) 2011-03-28 2017-06-14 Rosetta Genomics Ltd Methods for lung cancer classification
US9848778B2 (en) 2011-04-29 2017-12-26 Medtronic, Inc. Method and device to monitor patients with kidney disease
US9253630B2 (en) 2011-06-02 2016-02-02 Truphone Limited Identity management for mobile devices
WO2012167460A1 (en) * 2011-06-27 2012-12-13 华为技术有限公司 Method and apparatus for realizing mobility of local ip access or selected ip traffic offload
KR102023789B1 (en) * 2011-07-21 2019-09-20 바스프 에스이 Merocyanine derivatives
EP2758956B1 (en) 2011-09-23 2021-03-10 Digimarc Corporation Context-based smartphone sensor logic
US8744766B2 (en) * 2011-09-27 2014-06-03 International Business Machines Corporation Dynamic route recommendation based on pollution data
CN104054334B (en) 2011-12-21 2017-05-24 松下电器（美国）知识产权公司 Display device
CN104066736B (en) 2012-01-10 2017-03-08 拜耳知识产权有限责任公司 Substituted pyrazolopyrimidine as AKT kinase inhibitor
WO2013151647A1 (en) 2012-04-02 2013-10-10 Life Technologies Corporation Compositions and methods for detection of mycobacterium avium paratuberculosis
US9325569B2 (en) * 2012-06-29 2016-04-26 Hewlett Packard Enterprise Development Lp Implementing a software defined network using event records that are transmitted from a network switch
EP2913430B1 (en) * 2012-10-29 2017-08-09 Panasonic Intellectual Property Management Co., Ltd. Operating device
JP5864637B2 (en) 2013-03-19 2016-02-17 株式会社日立国際電気 Semiconductor device manufacturing method, substrate processing apparatus, program, and recording medium
US9369787B2 (en) * 2013-06-03 2016-06-14 Nokia Technologies Oy Shielded audio apparatus
US20150073515A1 (en) 2013-09-09 2015-03-12 Medtronic Ardian Luxembourg S.a.r.I. Neuromodulation Catheter Devices and Systems Having Energy Delivering Thermocouple Assemblies and Associated Methods
DE102013017586A1 (en) 2013-10-17 2015-05-07 Turbolite Vertriebs Gmbh TREATMENT DEVICE for Magnetic Field Assisted Irradiation Therapy
DE102013018179A1 (en) 2013-11-29 2015-06-03 Michael Feldmann Process and equipment for the production of absolutely greenhouse gas-free fuels
US9311639B2 (en) 2014-02-11 2016-04-12 Digimarc Corporation Methods, apparatus and arrangements for device to device communication
US9869658B2 (en) 2014-07-22 2018-01-16 International Business Machines Corporation Electronic label free detection of DNA complexes using nanogap
BR112017012634B1 (en) 2014-12-22 2021-09-28 Colgate-Palmolive Company UNIT DOSE CLOTHING SOFTENER AND CLOTHING SOFTENER METHOD
DE202015000313U1 (en) 2015-01-13 2015-03-20 Eugen Sarpaczki Gas mixing device
FR3032686B1 (en) 2015-02-18 2017-03-10 Messier Bugatti Dowty AIRCRAFT AIRCRAFT COMPRISING A TELESCOPIC LINEAR ROD
WO2016167787A1 (en) * 2015-04-17 2016-10-20 Halliburton Energy Services, Inc. Viscosifiers and filtration control agents for use in high temperature subterranean operations
EP3106256A1 (en) 2015-06-19 2016-12-21 Meyer Burger AG Method for cutting a workpiece
DE102016002678A1 (en) 2016-03-08 2017-09-14 GASKATEL Gesellschaft für Gassysteme durch Katalyse und Elektrochemie mbH Voltammetric measuring cell
US11197637B2 (en) 2016-06-20 2021-12-14 Faurecia Automotive Seating, Llc Control system for a vehicle seat
EP3301898A1 (en) 2016-09-29 2018-04-04 British Telecommunications public limited company Method and apparatus for transmitting data from a transmitter device to one or more receiver devices
DE202016006615U1 (en) 2016-10-26 2018-01-30 WIK - ELEKTROGERÄTE Entwicklungs- und Service-GmbH & Co. KG Hair styling device for applying a care substance by means of compressed air
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036471A2 (en) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2001048189A1 (en) * 1999-12-28 2001-07-05 Helix Research Institute Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same
WO2001059109A1 (en) * 2000-02-08 2001-08-16 Millennium Pharmaceuticals, Inc. 39406 protein, a seven transmembrane protein
WO2001062797A2 (en) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company G protein-coupled receptors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036471A2 (en) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
WO2001048189A1 (en) * 1999-12-28 2001-07-05 Helix Research Institute Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same
WO2001059109A1 (en) * 2000-02-08 2001-08-16 Millennium Pharmaceuticals, Inc. 39406 protein, a seven transmembrane protein
WO2001062797A2 (en) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company G protein-coupled receptors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EMBL; 16 March 2000 (2000-03-16), "Human DNA sequence", XP002200943, Database accession no. AL161458 *
SCHONEBERG T ET AL: "A novel subgroup of class I G-protein-coupled receptors", BIOCHIMICA ET BIOPHYSICA ACTA. GENE STRUCTURE AND EXPRESSION, ELSEVIER, AMSTERDAM, NL, vol. 1446, no. 1-2, 7 July 1999 (1999-07-07), pages 57 - 70, XP004275425, ISSN: 0167-4781 *
STADEL J M ET AL: "Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, vol. 18, no. 11, 1 November 1997 (1997-11-01), pages 430 - 437, XP004099345, ISSN: 0165-6147 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690853B2 (en) 2015-06-29 2023-07-04 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κβ for treatment of disease

Also Published As

Publication number Publication date
WO2002000001A2 (en) 2002-01-03
AU2001287574A1 (en) 2002-01-08

Similar Documents

Publication Publication Date Title
WO2002000001A3 (en) HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR20, AND USES THEREOF
Mintz et al. EHD1—an EH-domain-containing protein with a specific expression pattern
JP4357738B2 (en) TRAIN, a cysteine-rich receptor
ATE430198T1 (en) ANTIBODIES CONSTRUCTION USING A MRL/LPR MOUSE
NZ516004A (en) Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
Munoz et al. Expression and function of the Eph A receptors and their ligands ephrins A in the rat thymus
CN111019953A (en) Histidine engineered light chain antibodies and genetically modified non-human animals for production thereof
JP2001523977A (en) Activator of APAF-1, CED-4 human homolog, caspase-3
Kido et al. Expression of RANK is dependent upon differentiation into the macrophage/osteoclast lineage: induction by 1α, 25-dihydroxyvitamin D3 and TPA in a human myelomonocytic cell line, HL60
DK0647275T3 (en) Cloning and expression of the gonatotropin-releasing hormone receptor
Staudt et al. A panel of recombinant monoclonal antibodies against zebrafish neural receptors and secreted proteins suitable for wholemount immunostaining
WO2002002599A3 (en) HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF
WO2002002598A3 (en) HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR18, AND USES THEROF
WO2002002600A3 (en) HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF
WO2002000689A3 (en) HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR11, AND USES THEREOF
Herman Touch sensation in Caenorhabditis elegans
CN1898263B (en) Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof
Li et al. Heterologous expression of the adenosine A1 receptor in transgenic mouse retina
Beekman et al. Protein 4.1 G binds to a unique motif within the FcγRI cytoplasmic tail
MX2021008291A (en) A rodent model of mood disorders.
US20020115069A1 (en) Eh domain containing genes and proteins
Li et al. Belly roll, a GPI-anchored Ly6 protein, regulates Drosophila melanogaster escape behaviors by modulating the excitability of nociceptive peptidergic interneurons
ATE540965T1 (en) OB RECEPTOR AND METHOD FOR DIAGNOSIS AND TREATMENT OF WEIGHT
JP3842647B2 (en) Interleukin-1 receptor antagonist related molecule and use thereof
CA2404563A1 (en) Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP